WithdrawnNot Applicable

Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

South Africa0Started 2014-05

Plain-language summary

Compare anticapsular antibody levels against Group B Streptococcus at delivery in mothers and their infants who develop disease versus those who do not. Use this comparison to establish antibody levels associated with reductions in risk of GBS disease in infants aged less than 90 days.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women attending participating community/hospital antenatal clinics and/or delivering at participating delivery centers. * Subjects aged ≥18 years. * Able to understand and comply with planned study procedures. * Provides written informed consent. Exclusion Criteria: * Refuses to consent to study participation.

What they're measuring

Early onset Group B Streptococcus Disease due to serotypes Ia or III

Timeframe: 0-6 days

Trial details

NCT IDNCT02099149

SponsorNovartis

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-08

View on ClinicalTrials.gov More Invasive Group B Streptococcus Disease trials